RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+33.41%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.57B
AUM Growth
+$452M
(+21%)
Cap. Flow
-$55.1M
Cap. Flow
% of AUM
-2.14%
Top 10 Holdings %
Top 10 Hldgs %
31.92%
Holding
139
New
6
Increased
46
Reduced
13
Closed
9
Top Buys
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
+$20.7M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$20M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$16.9M |
| 4 |
Cigna
CI
|
+$14.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$10.8M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
+$44.7M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$33.8M |
| 3 |
Molina Healthcare
MOH
|
+$19.1M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$18.7M |
| 5 |
Biogen
BIIB
|
+$15M |
Sector Composition
| 1 | Healthcare | 86.14% |
| 2 | Consumer Staples | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Zimmer Biomet
ZBH
$20.7B
| – | – |
-121,025
| Closed | -$12.2M |
|
|
GTHX
127
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-100,000
| Closed | -$1.92M |
|
|
APTX
128
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-305,000
| Closed | -$5.05M |
|
|
LOXO
129
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-241,500
| Closed | -$33.8M |
|
|
TSRO
130
DELISTED
TESARO, Inc.
TSRO
| – | – |
-601,700
| Closed | -$44.7M |
|